News

For Kimberly, Clinical Trials Were a Leap of Faith

1 October 2018 In Melanoma Stories

Kimberly was just 19-years-old when she noticed the black “freckle” on her foot. But it wasn’t until she was 22-years-old and pregnant with her first child that her “freckle” became a cause for concern.

Read More


Ipilimumab Cured Dan Engel He’s Committed to Paying it Forward

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 24 September 2018 In Melanoma Stories

Dan needed a miracle. At this point, he’d had six surgeries on his neck, endured radiation therapy, and been enrolled in five clinical trials. Dan’s miracle came in 2006 in the form of an experimental drug, ipilimumab or anti-CTLA4 antibody, that would later be named Yervoy. This drug would later become the first new FDA-approved melanoma treatment in 13 years.

Read More


Right Place, Right Time, Right Trial

10 September 2018 In Melanoma Stories, Treatment

Jonathan is cancer free because he was in the right place at the right time to be enrolled in a clinical trial. Read his story.

Read More


Are you #SunSavvy365?

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 4 September 2018 In Allies & Partnerships, Prevention

​It’s easy to think of sunscreen when you are lounging by a pool, but did you know that it’s important to protect yourself and those you love every day of the year? That’s why MRA partnered with the Melanoma Action Coalition to create #SunSavvy365, a social media campaign that reminds us to protect our skin whether we are making sand castles or snowmen.

Read More


Using Zebrafish to Shed New Light on Melanoma

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 29 August 2018 In Science

Dr. Liz Patton, a MRA-funded cancer researcher at the Medical Research Council Human Genetics Unit at the University of Edinburgh, is fascinated by learning how things work. Patton has focused her research on better understanding how melanocytes – the cells in our skin that provide us our coloring – develop, divide, migrate, and in some unfortunate circumstances, proliferate uncontrollably turning into melanoma. Her work is providing critical insight into the origin of melanoma and what spurs melanoma to spread throughout the body.

Read More


Barriers to Safety: The Push for Sunscreen Access in Schools

17 August 2018 In Prevention

Why are there laws against having sunscreen in school in over half of U.S. states? All it takes is one sunburn during childhood to doublethe risk of melanoma in adulthood. And yet, as of July 2018, only 16 states have passed laws that allow kids to have sunscreen in school. This is a serious problem with a common-sense solution, so what’s the hold up?

Read More


Maintaining the Pace of Melanoma Innovation in the Era of an Evolving Standard of Care

10 August 2018 In Science, Treatment

There is no doubt that treatments for metastatic melanoma have changed dramatically in the decade since MRA’s founding in 2007. How do we keep up the momentum?

Read More


Choosing the Right Sunscreen - Your Questions Answered

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 2 August 2018 In Prevention

Bold claims and conflicting advice about what goes into a good sunscreen make it easy to feel overwhelmed when buying sunscreen. At MRA, we believe that the best sunscreen is one that you will wear. Provided that it meets three simple rules:

Read More


Wiser & Stronger – Life after Metastatic Melanoma

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 20 July 2018 In Melanoma Stories, Treatment

For Derrick, it all started with headaches. For the first time in his life, this otherwise perfectly healthy father of two, knew something was wrong.

Read More


Uveal ‘Clusters’ in Auburn, AL and Huntersville, NC

By Cody Barnett, MPH, MRA Senior Director of Communications & Patient Engagement | 18 July 2018 In Allies & Partnerships, Melanoma Stories, News, Science, Treatment

When we talk about melanoma, it’s easy to forget that cutaneous – the most common variety that forms on the skin – isn’t the only game in town. Uveal represents about 5% of all melanomas diagnosed each year. So, when dozens of people from two towns in North Carolina and Alabama were diagnosed with the rare cancer alarm bells sounded.

Read More


Login

×